Mycotic Abdominal Aortic Aneurysm after Adjuvant Therapy with Bacillus Calmette-Guérin in Patients with Urothelial Bladder Cancer: A Rare but Misinterpreted Complication
| Autor: | Giovanni Lorenzi, Alessandro L.C. Molinari, Stefano A. Ferrari, Enrico Leo, Angelo Terzi, Gian Paolo Rossi |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Male
medicine.medical_specialty Time Factors Aortic Rupture Antitubercular Agents Primary care Aortography Sepsis Blood Vessel Prosthesis Implantation Risk Factors medicine Adjuvant therapy Humans Neoplasm Invasiveness In patient Aged Neoplasm Staging Aged 80 and over Bladder cancer business.industry Endovascular Procedures General Medicine medicine.disease Abdominal aortic aneurysm Surgery Administration Intravesical Treatment Outcome Urinary Bladder Neoplasms BCG Vaccine cardiovascular system Intravesical bcg Radiology Urothelium Tomography X-Ray Computed Cardiology and Cardiovascular Medicine Complication business Aneurysm Infected Aortic Aneurysm Abdominal |
| Zdroj: | Annals of Vascular Surgery. 29:1318.e1-1318.e6 |
| ISSN: | 0890-5096 |
| DOI: | 10.1016/j.avsg.2015.01.036 |
| Popis: | Bacillus Calmette-Guérin (BCG) therapy is often associated with side effects. The most feared is disseminated sepsis that may occur rarely with the development of mycotic aortic aneurysms. Twenty cases of patients treated with intravesical BCG complicated by mycotic abdominal aortic aneurysm have been reported in the literature, including 2 cases of the present study. Delayed vascular work-up represents a critical aspect. Mycotic aneurysms evidence a rapid progression. Primary care physicians and urologists should be sensitized to recognize unspecified symptoms such as potential clinical manifestations of a mycotic abdominal aortic aneurysm, even several months or years after BCG therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|